logo
Select company
Select metric
11.41%Cash to Assets Ratio
VS
Market
60
Sector
27
Industry
13
History
22
$ 2.84Close
$ 0.73 - $ 2.84 52-Week Range
Ticker Information

Ticker

CRBU

Company Name

CARIBOU BIOSCIENCES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARIBOU BIOSCIENCES INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CRBU - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 220.9M$ 25.2M11.41%
3/31/2025$ 273.66M$ 29.42M10.75%
12/31/2024$ 313.31M$ 16.29M5.2%
9/30/2024$ 344.33M$ 31.97M9.28%
6/30/2024$ 372.94M$ 37.87M10.15%
3/31/2024$ 406.82M$ 49.4M12.14%
12/31/2023$ 432.21M$ 51.16M11.84%
9/30/2023$ 457.52M$ 104.06M22.74%
6/30/2023$ 349.65M$ 66.19M18.93%
3/31/2023$ 347.46M$ 52.74M15.18%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARIBOU BIOSCIENCES INC's latest trailing twelve months (TTM) Cash to Assets stands at 44.26%.
  • Over the past 5 years, CARIBOU BIOSCIENCES INC's average Cash to Assets has been 30.79%.
  • The median Cash to Assets for CARIBOU BIOSCIENCES INC during this period was 18.93%
  • CARIBOU BIOSCIENCES INC reached its highest Cash to Assets over the past 5 years at 94.23%.
  • The lowest Cash to Assets recorded by CARIBOU BIOSCIENCES INC in the same timeframe 5.2%

CARIBOU BIOSCIENCES INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
KRRO : KORRO BIO INC 18.63%TVRD : TVARDI THERAPEUTICS INC 47.2%TCRX : TSCAN THERAPEUTICS INC 58.42%ACOG : ALPHA COGNITION INC 87.46%CRVO : CERVOMED INC 21.85%FATE : FATE THERAPEUTICS INC 13.85%OVID : OVID THERAPEUTICS INC 39.19%OBIO : ORCHESTRA BIOMED HOLDINGS INC 43.78%VERU : VERU INC 54.92%CBUS : CIBUS INC 10.53%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for CARIBOU BIOSCIENCES INC is calculated as follows: CashnEq [ $ 15.95M ] / Assets [ $ 36.05M ]
(=) Cash to Assets [ 44.26% ]

CRBU - Cash to Assets Ratio, Last 5 years

5.2%

Minimum

Dec 31, 2024

94.23%

Maximum

Sep 30, 2021

30.79%

Average

18.93%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.79% with a standard deviation of 9.55%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.8%
average9.79%
median6.44%
std9.55%